Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K041202
    Manufacturer
    Date Cleared
    2004-08-12

    (97 days)

    Product Code
    Regulation Number
    864.6550
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    HEMOSURE ONE-STEP FECAL OCCULT BLOOD TEST

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Hemosure™ One-Step Fecal Occult Blood (FOB) Test is an immunochemical device intended for the qualitative detection of Fecal Occult Blood by laboratories or physicians offices. It is useful to determine gastrointestinal (GI) bleeding found in a number of GI disorders, e.g. diverticulitis, colitis, polyps, and colorectal cancer.

    Device Description

    The Hemosure™ One-Step FOB Test is a lateral flow immunoassays intended for the detection of fecal occult blood.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study details for the Hemosure™ One-Step Fecal Occult Blood (FOB) Test, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria (Stated or Implied)Reported Device Performance
    Sensitivity
    Detect human hemoglobin at 50 ng hHb/mL100% positive results for samples ≥ 50 ng hHb/mL
    Specificity/Non-interference
    No interference from dietary substancesStated: "Neither dietary substances nor toilet water fresheners or cleansers interfere"
    No interference from toilet waterStated: "Neither dietary substances nor toilet water fresheners or cleansers interfere"
    No cross-reactivity with non-human hemoglobinStated: "does not cross-react with hemoglobin from other species."
    Positive results only for human hemoglobinStated: "gives positive results only when human hemoglobin with sufficient concentration is present."
    Overall Accuracy
    N/A (implied high agreement with expected results)Overall accuracy: 98%
    Agreement with predicate device (for sensitivity)100% agreement with predicate device (for sensitivity at concentrations ≥ 50 ng hHb/mL)

    2. Sample Size Used for the Test Set and Data Provenance

    • Sensitivity Test Set:
      • Sample Size: 50 extracted stool samples.
      • Data Provenance: "collected in house" - implies internal to WHPM, Inc. Retrospective, as samples were collected and then spiked.
    • Overall Accuracy Test Set:
      • Sample Size: 100 extracted stool samples.
      • Data Provenance: "collected in house" - implies internal to WHPM, Inc. Retrospective, as samples were collected and then spiked.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    The document does not mention the use of experts to establish the ground truth for the test set. Instead, the ground truth was established by spiking known concentrations of human hemoglobin into negative stool samples.

    4. Adjudication Method for the Test Set

    No adjudication method is mentioned. The ground truth was established by direct spiking of known concentrations of human hemoglobin. The "expected results" were based on these known concentrations.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No, a multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly described. The study involved testing the device at different laboratories (physician's office, reference laboratory, WHPM Inc. laboratory), which suggests multiple readers, but it does not detail a comparison of human readers with vs. without AI assistance. This is a diagnostic device, not an AI-assisted diagnostic tool.

    6. Standalone (i.e. algorithm only without human-in-the-loop performance) Study

    Yes, a standalone study was performed. The device, an immunoassay, is designed to be read directly. The "studies were performed in three sites" and "tested with the Hemosure™ One-Step FOB Test" directly, meaning the device's performance itself was evaluated against known ground truth without human interpretive assistance being measured as a variable.

    7. Type of Ground Truth Used

    The ground truth used was known concentrations of spiked human hemoglobin (hHb) in stool samples that were initially free of human hemoglobin. This is an engineered ground truth for analytical performance rather than a clinical ground truth from patient outcomes or pathology.

    8. Sample Size for the Training Set

    The document does not specify a separate training set or its sample size. For an immunoassay device, the "training" typically refers to the development and optimization of the assay itself, rather than training a machine learning algorithm.

    9. How the Ground Truth for the Training Set Was Established

    As no specific training set for an algorithm is mentioned, this question is not directly applicable. For the device's development/optimization, the ground truth would likely have been established through controlled experiments with known concentrations of analytes, similar to how the test set's ground truth was established.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1